Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

被引:49
作者
Garderet, L
Snell, V
Przepiorka, D
Schenk, T
Lu, JG
Marini, F
Gluckman, E
Andreeff, M
Champlin, RE
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Mol Hematol & Therapy, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
关键词
D O I
10.1097/00007890-199901150-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. T cells present in an allogeneic bone marrow transplant may produce graft-versus-host disease but also contribute to immune reconstitution and enhance engraftment. Our aim was to separate alloreactive from nonalloreactive T lymphocytes, by performing a mixed lymphocyte culture (MLC) stimulation of donor cells, followed by selective depletion of activated cells expressing the high-affinity interleukin 2 receptor. We then characterized the resulting depleted cell fraction. Methods. Donor peripheral blood mononuclear cells were cocultured with irradiated peripheral blood mononuclear cells from HLA-nonidentical recipient stimulators in an MLC. After 3 days, CD25(+) lymphocytes (alloreactive cells expressing the alpha chain of the interleukin 2 receptor) were removed by immunomagnetic separation. The depleted donor fraction and untreated cells were then rechallenged in a secondary MLC with the original irradiated stimulator cells or a third party to assess relative alloreactivity. Results. Inhibition of the secondary MLC and of host-specific cytotoxic activities was observed as well as a disappearance of interleukin 2 receptor-positive cells. Alloreactivity against unrelated third-party cells was preserved. Limiting dilution analysis of residual alloantigen-reactive T lymphocytes demonstrated a 1.3 log reduction of antihost reactivity, The depletion largely removed host-specific alloreactive CD4(+) cells. Conclusions. This method reduces alloreactivity while retaining reactivity against third-party targets. This approach may allow therapeutic infusion of T cells after HLA-nonidentical allografts with a reduced capacity to produce graft-versus-host disease.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 39 条
[1]   EFFECT OF HLA COMPATIBILITY ON ENGRAFTMENT OF BONE-MARROW TRANSPLANTS IN PATIENTS WITH LEUKEMIA OR LYMPHOMA [J].
ANASETTI, C ;
AMOS, D ;
BEATTY, PG ;
APPELBAUM, FR ;
BENSINGER, W ;
BUCKNER, CD ;
CLIFT, R ;
DONEY, K ;
MARTIN, PJ ;
MICKELSON, E ;
NISPEROS, B ;
OQUIGLEY, J ;
RAMBERG, R ;
SANDERS, JE ;
STEWART, P ;
STORB, R ;
SULLIVAN, KM ;
WITHERSPOON, RP ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :197-204
[2]   SUCCESSFUL ENGRAFTMENT OF T-CELL-DEPLETED HAPLOIDENTICAL 3-LOCI INCOMPATIBLE TRANSPLANTS IN LEUKEMIA PATIENTS BY ADDITION OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS TO BONE-MARROW INOCULUM [J].
AVERSA, F ;
TABILIO, A ;
TERENZI, A ;
VELARDI, A ;
FALZETTI, F ;
GIANNONI, C ;
IACUCCI, R ;
ZEI, T ;
MARTELLI, MP ;
GAMBELUNGHE, C ;
ROSSETTI, M ;
CAPUTO, P ;
LATINI, P ;
ARISTEI, C ;
RAYMONDI, C ;
REISNER, Y ;
MARTELLI, MF .
BLOOD, 1994, 84 (11) :3948-3955
[3]   Graft-versus-leukaemia: Understanding and using the alloimmune response to treat haematological malignancies [J].
Barrett, AJ ;
Malkovska, V .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :754-761
[4]   MARROW TRANSPLANTATION FROM RELATED DONORS OTHER THAN HLA-IDENTICAL SIBLINGS [J].
BEATTY, PG ;
CLIFT, RA ;
MICKELSON, EM ;
NISPEROS, BB ;
FLOURNOY, N ;
MARTIN, PJ ;
SANDERS, JE ;
STEWART, P ;
BUCKNER, CD ;
STORB, R ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :765-771
[5]   GRAFT-VERSUS-LEUKEMIA REACTIVITY INDUCED BY ALLOIMMUNIZATION WITHOUT AUGMENTATION OF GRAFT VERSUS HOST REACTIVITY [J].
BORTIN, MM ;
TRUITT, RL ;
RIMM, AA ;
BACH, FH .
NATURE, 1979, 281 (5731) :490-491
[6]   SPECIFIC ELIMINATION OF ALLOREACTIVE T-CELLS BY AN ANTI-INTERLEUKIN-2 RECEPTOR B-CHAIN-SPECIFIC IMMUNOTOXIN [J].
CAVAZZANACALVO, M ;
FROMONT, C ;
LEDEIST, F ;
LUSARDI, M ;
COULOMBEL, L ;
DEROCQ, JM ;
GEROTA, I ;
GRISCELLI, C ;
FISCHER, A .
TRANSPLANTATION, 1990, 50 (01) :1-7
[7]  
CAVAZZANACALVO M, 1994, BLOOD, V83, P288
[8]   Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].
Collins, RH ;
Shpilberg, O ;
Drobyski, WR ;
Porter, DL ;
Giralt, S ;
Champlin, R ;
Goodman, SA ;
Wolff, SN ;
Hu, W ;
Verfaillie, C ;
List, A ;
Dalton, W ;
Ognoskie, N ;
Chetrit, A ;
Antin, JH ;
Nemunaitis, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444
[9]   CONTINGENT GENETIC REGULATORY EVENTS IN LYMPHOCYTE-T ACTIVATION [J].
CRABTREE, GR .
SCIENCE, 1989, 243 (4889) :355-361
[10]  
DATTA AR, 1994, BONE MARROW TRANSPL, V14, P517